Gregory Stein
Company: Curtana Pharma
Job title: CEO
Seminars:
Addressing Tumor Heterogeneity & Multiple Cellular States: Is Combination Targeted Therapy the Answer? 4:00 pm
Unveiling research into the complexity of tumor heterogeneity in GBM Reviewing preclinical data of one approach combining CT-179, an OLIG2 inhibitor, with EGFR inhibitors Exploring areas of potential research to identify and test scientifically rational combinations of targeted therapeuticsRead more
day: Conference Day 1